"10.1371_journal.pone.0067316","plos one","2013-06-26T00:00:00Z","Olivier Nolan-Stevaux; Donato Tedesco; Seamus Ragan; Mikhail Makhanov; Alex Chenchik; Astrid Ruefli-Brasse; Kim Quon; Paul D Kassner","Oncology Research, Amgen, South San Francisco, California, United States of America; Cellecta Inc., Mountain View, California, United States of America; Genome Analysis Unit, Amgen, South San Francisco, California, United States of America; Therapeutic Innovation Unit, Amgen, Seattle, Washington, United States of America","Conceived and designed the experiments: ONS DT KQ PK. Performed the experiments: ONS DT SR. Analyzed the data: ONS DT SR MM. Contributed reagents/materials/analysis tools: AC. Wrote the paper: ONS DT. Supervised the research program: ARB.","Cellecta, Inc. was a provider of lentiviral shRNA libraries for this study and is the employer of Donato Tedesco, Mikhail Makhanov and Alex Chenchik. Olivier Nolan-Stevaux, Seamus Ragan, Astrid Ruefli-Brasse, Kim Quon and Paul D. Kassner are employed by Amgen. This study was funded by Amgen Inc. There are no further patents, products in development or marketed products to declare. This does not alter the authorsâ€™ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","06","Olivier Nolan-Stevaux","ONS",8,TRUE,4,3,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
